

5-minute health questionnaire reviewed by a licensed physician within 24 hours.

If approved, your physician creates a personalized protocol tailored to your health profile.

Pharmacy-compounded medications shipped directly to your door with COA included.
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to produce growth hormone. Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin. Together, they create a synergistic effect — CJC-1295 amplifies GH pulses while Ipamorelin triggers their release, resulting in sustained elevation of growth hormone without the side effects of direct GH administration. This supports recovery, sleep quality, lean muscle, and body composition.


All medications carry potential risks. Common side effects of CJC-1295 / Ipamorelin may include:
This is not a complete list of side effects. Your prescribing physician will discuss protocol-specific risks during your consultation. Report any adverse reactions immediately.
The combination creates a synergistic effect — CJC-1295 extends GH release duration while Ipamorelin triggers the pulse. Together they're more effective than either alone, with fewer side effects than direct GH.
Many patients report significantly improved sleep quality, particularly deeper restorative sleep phases. Some experience vivid dreams, which is generally considered a positive sign.
Your physician will provide specific timing guidance. Many protocols recommend evening administration to align with natural GH release patterns during sleep.
No. CJC-1295/Ipamorelin stimulate your body's own growth hormone production rather than introducing external GH. This results in more physiologic GH patterns with fewer side effects.